6
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Clinical Chemistry: The Esterification of Cholesterol in Plasma after Acute Myocardial Infarction

, , , &
Pages 181-187 | Received 24 Aug 1974, Accepted 01 Nov 1974, Published online: 28 Aug 2009
 

Abstract

Ritland, S., Blomhoff, J. P., Enger, S. C., Skrede, S. & Gjone, E. The Esterification of Cholesterol in Plasma after Acute Myocardial Infarction. Scand. J. clin. Lab. Invest. 35, 181–187, 1975.

The rate of plasma cholesterol esterification (LCAT activity) and the concentration of eight proteins in the plasma have been studied in ten male patients during the course of acute myocardial infarction. Samples were drawn 22 hr, 3 days, 8 days, 2 weeks, and 7 weeks after the onset of the acute myocardial infarction. The changes of the plasma proteins were typical for the acutephase reaction. LCAT activity decreased initially during the illness. The lowest values were found after 8 days. Concomitantly, a reduction in the plasma concentration of total and free cholesterol and cholesteryl esters was demonstrated. The rate of cholesterol esterification correlated significantly with the concentration of prealbumin, α-lipoprotein, and albumin. Seven weeks after onset of the infarction, the LCAT values were equal to those in a reference group. The results suggest that the synthesis of LCAT was decreased during the acute-phase reaction.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.